Lab of nutrient sensing in metabolic diseases aims to understand how lipid metabolite ceramides: impair nutrient sensing in adipose tissue and contribute to development of metabolic diseases such as obesity, diabetes, cardiovascular diseases etc. (Chaurasia et 2016, Cell Metabolism and Chaurasia et 2019, Science). Using genetic and pharmacological tools to modulate ceramide accumulation in vivo combined with unbiased approaches we have to identified a downstream effector molecule of ceramide, that bestows ceramides some of these functions. We are currently seeking a postdoctoral candidate with background in biomedical sciences to investigate the role of this newly identified protein in development of metabolic diseases. We anticipate the start date to be 07/01/2020 or later. Successful applicants will be generously offered with NIH guideline-based salary and benefits and will be part of diabetes research community at University of Iowa Hospital and Clinics and affiliated Fraternal order of diabetes research institute. In addition to existing projects in the lab, he/she will be provided with sufficient support and freedom to ask new important questions and independently develop innovative research in the general context of laboratory interest.
With over 31,000 students, the University of Iowa is one of the nation's top public research universities, a member of the Big Ten conference and the Association of American Universities. The University of Iowa is composed of eleven colleges and is known around the world for its balanced commitment to the arts, sciences, and humanities. It is home to one of the nation's largest academic medical centers and the pioneering Iowa Writers' Workshop. The University of Iowa promotes work/life integration and is located in the casual yet cosmopolitan environment of Iowa City, widely recognized as one of the country's most livable communities.